MitoPRO X
6 wavelengths, touchscreen, app control. Medical-grade performance.
from $449.00
MitoADAPT 4.0
8 wavelengths, 11 modes, patent-pending TruDUAL™ chip technology.
from $549.00
MitoPRO+
4 wavelengths, exceptional power, unbeatable value.
from $369.00
Mito Red Original 2.0
660nm + 850nm. ETL certified. Great value starting point.
from $249.00
MitoAURA Complete System
MitoAURA 3-Step System is the first skincare protocol engineered to work with your red and near-infrared light therapy sessions, not just alongside them.
from $93.00
MitoAURA Serum
Light-responsive. Firms, brightens, and amplifies every session.
from $40.00
MitoGLOW Mask
FDA-cleared LED mask. 1,064 LEDs, 4 wavelengths, 5 modes.
from $499.00
MitoAURA™ Gentle Cleanser
Gently cleanses without stripping skin's natural moisture.
from $25.00
MitoAURA™ Prime Pre-LED Serum
Helps prepare and condition skin for red light therapy.
from $39.00
MitoAURA™ Seal Post LED Moisturizer
Helps lock in moisture and support long-lasting hydration.
from $39.00
MitoPRO Mobile
5 wavelengths, pulse mode, UL-listed battery. Pro light anywhere.
from $349.00
MitoQUAD Belt
Hands-free wearable belt. UL medical grade, 4 wavelengths.
from $349.00
MitoPOD
Full-body pod. IEC 60601 certified, 6,960 LEDs total.
from $1,699.00
MitoBOOST
Intranasal device. Red, blue & NIR for sinus, immune & brain.
from $199.00
What is Red Light Therapy
The science behind PBM — how red and near-infrared light works at the cellular level.
The Mito Red Difference
Why our devices outperform — specs, certifications, and build quality explained.
In the Press
Media coverage, expert reviews, and editorial features.
FAQ
Common questions about devices, protocols, safety, and shipping.
Take the Quiz
Four quick questions to find the right panel for your goals.
Research & Evidence
Browse the clinical studies and data behind photobiomodulation therapy.
Community
Meet the Mito Red community — real people, real results.
Four quick questions. One recommendation.
By treatment area
Formulated to work with light — not just alongside it. Young Goose collab. EWG Green. Made in USA.
BEST VALUE
COMING SOON
STEP 1
STEP 2
STEP 3
About the research on this page. The studies cited here investigate photobiomodulation (PBM) as a therapeutic modality and the specific wavelengths used in PBM research — not Mito Red Light devices. The wavelengths in our panels were chosen because the peer-reviewed PBM literature supports them. Evidence levels and study counts reflect the broader research base, not studies of our products. See the full methodology note at the bottom of this page.
Laser and light therapy is widely used in veterinary practice, but the evidence is mixed. A 2023 systematic review of 45 studies in dogs, cats and horses found conflicting results and no consensus on treatment settings (Millis 2023). Some randomized trials in dogs are positive: in 40 dogs with osteoarthritis, light therapy improved pain scores, function and range of motion for up to 90 days (Alves 2022), and in chronic wounds it increased the reduction in wound area at 15 days (Hoisang 2021). A small trial of contaminated wounds found lower bacterial counts at 2 J/cm² (Rico-Holgado 2021).
Other dog studies are null. In acral lick dermatitis, adding laser did not improve lesion size or severity, although hair regrowth increased (Schnedeker 2021). After cruciate ligament surgery, evidence that laser improves bone healing is inconclusive (Moore 2025).
Based on 84 indexed studies in this category. These studies test photobiomodulation in general, not Mito Red Light devices.
The strongest human evidence: systematic reviews and meta-analyses first, then the newest randomized trials. Each card comes straight from our study database and links to the paper.
Millis & Bergh et al., Animals (Basel), 2023. PMID 36830454
Moore L et al., Vet Evid, 2025. PMID 42006389
Hoisang et al., Vet World, 2021. PMID 34566346
Schnedeker et al., Vet Dermatol, 2021. PMID 33471429
Rico-Holgado et al., J Lasers Med Sci, 2021. PMID 35155163
Alves et al., Am J Vet Res, 2022. PMID 35895799
Not every trial is positive. "No effect" means the main outcome did not differ from sham or control. "Mixed" means some outcomes improved but the outcome named here did not differ.
| Year | Study | Design | Result | Outcome with no difference |
|---|---|---|---|---|
| 2025 | Does LLLT improve radiographic healing for dogs with cranial cruciate ligament rupture undergoing TPLO surgery? | Systematic review | No effect | Radiographic bone healing in dogs (inconclusive) |
| 2021 | Is low-level laser therapy useful as an adjunctive treatment for canine acral lick dermatitis? A randomized, double-blinded, sham-controlled study | RCT | No effect | Licking score (primary outcome) and lesion size in dogs; hair regrowth improved |
In a double-blind randomized trial of 40 dogs with osteoarthritis, light therapy improved pain scores, function and range of motion for up to 90 days (Alves 2022).
In a randomized trial, chronic wounds shrank more with light therapy at 15 days (Hoisang 2021), and a small trial found lower bacterial counts in contaminated wounds (Rico-Holgado 2021).
Not yet. A review of 45 studies found conflicting results and no consensus on settings (Millis 2023).
All 84 studies in this category from our study database, built on the PBM Research Database by Vladimir Heiskanen.
Search every study across all categories: Open the Full Evidence Explorer →
The published research indexed and referenced on this page studies photobiomodulation (PBM) as a therapeutic modality and the specific wavelengths used in those studies — not Mito Red Light devices specifically. The wavelengths used across our panels were chosen because the peer-reviewed PBM literature supports them: this is where published evidence is deepest, where dosing parameters have been characterized in human studies, and where clinical guidelines (such as WALT for inflammation and pain) exist. Mito Red Light has not funded or conducted registered clinical trials on our specific devices, and the study counts referenced here reflect the broader PBM research base — not studies of our products.
Where review authors graded certainty (for example with GRADE), we report their grade; other ratings are Mito’s summary. Study counts reflect peer-reviewed photobiomodulation research drawn from major scientific literature databases, peer-reviewed journals, and other published research repositories. PBM response varies meaningfully by person, tissue, condition, dose, wavelength, and session timing; outcomes reported in the published literature may not be replicable for every user. Mito Red Light devices are not intended to diagnose, treat, cure, or prevent any disease. If you have a medical condition or are under a physician’s care, please consult your healthcare provider before beginning any photobiomodulation regimen.
